Solid Biosciences  logo
Solid Biosciences SLDB
$ 5.69 -1.13%

Quarterly report 2024-Q2
added 08-13-2024

report update icon

Solid Biosciences Balance Sheet 2011-2024 | SLDB

Annual Balance Sheet Solid Biosciences

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-70.9 M -152 M -118 M - -69 M -85.3 M -52.1 M -7.68 M -28.6 M - - - -

Long Term Debt

1.23 M 1.7 M 275 K - - - - - - - - - -

Long Term Debt Current

1.86 M 1.9 M 1.26 M 2 M 1.74 M - - - - - - - -

Total Non Current Liabilities

- - - - 5.15 M 1.93 M 124 M 71.6 M 61.7 M - - - -

Total Current Liabilities

14.5 M 22.5 M 23.6 M 24.5 M 18.3 M 12.5 M - - - - - - -

Total Liabilities

38.5 M 48.6 M 24.2 M 39.1 M 23.4 M 14.4 M 135 M 78.5 M 75.6 M - - - -

Deferred Revenue

- - - 10.4 M - - - - - - - - -

Retained Earnings

-659 M -563 M -477 M -405 M -316 M -199 M -124 M -84.9 M -67.7 M - - - -

Total Assets

165 M 260 M 232 M 171 M 103 M 140 M 76.2 M 40.6 M 55.7 M - - - -

Cash and Cash Equivalents

74 M 155 M 119 M 155 M 76 M 86.4 M 52.1 M 7.84 M - - - - -

Book Value

126 M 212 M 208 M 132 M 80 M 125 M -59.3 M -37.9 M -19.9 M - - - -

Total Shareholders Equity

126 M 212 M 208 M 132 M 80 M 125 M -59.3 M - - - - - -

All numbers in USD currency

Quarterly Balance Sheet Solid Biosciences

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

953 K 1.1 M 1.23 M 23.2 M 23.6 M 23.9 M 24.3 M - 24.5 M 231 K 293 K 353 K 412 K 469 K 525 K 525 K 525 K 525 K 733 K 733 K 733 K 733 K 859 K 859 K 859 K 859 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

23 M - 23.9 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

37.7 M 38 M 38.5 M 40.4 M 41 M 45.8 M 48.6 M 41.2 M 46.3 M 22 M 24.2 M 25.6 M 27.9 M 32.3 M 39.1 M 39.1 M 39.1 M 39.1 M 23.4 M 23.4 M 23.4 M 23.4 M 14.4 M 14.4 M 14.4 M 14.4 M 11.3 M 11.3 M 11.3 M 11.3 M - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

- - - - - - - - - 6.17 M 8.08 M 8.86 M 10 M 10.7 M 10.4 M 10.4 M 10.4 M 10.4 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-708 M -683 M -659 M -638 M -617 M -593 M -563 M -548 M -527 M -502 M -477 M -458 M -440 M -421 M -405 M -405 M -405 M -405 M -316 M -316 M -316 M -316 M -199 M -199 M -199 M -199 M -124 M -124 M -124 M -124 M - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

231 M 249 M 165 M 185 M 205 M 230 M 260 M 184 M 208 M 208 M 232 M 249 M 266 M 285 M 171 M 171 M 171 M 171 M 103 M 103 M 103 M 103 M 140 M 140 M 140 M 140 M 76.2 M 76.2 M 76.2 M 76.2 M - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

95.9 M 118 M 74 M 49 M 91.6 M 165 M 155 M 48.8 M 54.3 M 130 M 119 M 110 M 201 M 268 M 155 M 155 M 155 M 155 M 76 M 76 M 76 M 76 M 86.4 M 86.4 M 86.4 M 86.4 M 52.1 M 52.1 M 52.1 M 52.1 M 7.68 M - - - 28.6 M - - - - - - - - - - - - - - - - - - -

Book Value

193 M 211 M 126 M 144 M 164 M 184 M 212 M 143 M 162 M 186 M 208 M 223 M 238 M 253 M 132 M 132 M 132 M 132 M 80 M 80 M 80 M 80 M 125 M 125 M 125 M 125 M 64.9 M 64.9 M 64.9 M 64.9 M - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

193 M 211 M 126 M 144 M 164 M 184 M 212 M 143 M 162 M 186 M 208 M 223 M 238 M 253 M 132 M 132 M 132 M 132 M 80 M 80 M 80 M 80 M 125 M 125 M 125 M 125 M -59.3 M -59.3 M -59.3 M -59.3 M -37.9 M - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency